Fredun Pharmaceuticals Allots 11,025,380 Bonus Equity Shares

Fredun Pharmaceuticals Limited announced the allotment of 11,025,380 fully paid-up Bonus Equity Shares. The allotment was made in a 2:1 ratio, meaning two new bonus shares for every one existing equity share held as of the record date, July 16, 2026. The face value of each share is ₹10. This bonus issue increases the company's issued and paid-up equity share capital from ₹5,51,26,900 (5,512,690 shares) to ₹16,53,80,700 (16,538,070 shares). The newly allotted bonus shares will rank pari-passu with existing equity shares, carrying identical rights including future dividends.